Astellas Gene Therapies — 5 Decision Makers

Main page
Healthcare & Medical
Astellas Gene Therapies

About Astellas Gene Therapies

Astellas Gene Therapies is a public company operating in the Biotechnology Research industry, It specializes in gene therapy, and biotechnology, and is headquartered in San Francisco, United States, with approximately 201-500 employees.

Leadership & Decision Makers

Contact details of 5 Astellas Gene Therapies decision makers

Lovena Chaput

Senior Vice President, Americas & Asia Pacific

0 Emails

0 Phones

Search Emails

Helga Stockton

Vice President, Quality

0 Emails

0 Phones

Search Emails

Fulvio Mavilio

SVP Translational Science

0 Emails

0 Phones

Search Emails

Carlos Fonck, PhD

Senior Director, Head of Pharmacology & Toxicology

0 Emails

0 Phones

Search Emails

Paul Bonham

Executive Director, Managed Markets

0 Emails

0 Phones

Search Emails

Verify Astellas Gene Therapies Emails

Similar Companies like Astellas Gene Therapies

Clarify Health Solutions

clarifyhealth.com

Big Data & Analytics · San Francisco, CA · Est. 2015 · 101–250 employees

HQ: San Francisco, CA

Tempus

tempus.com

AI & Machine Learning · Chicago, IL · Est. 2015 · 501–1000 employees · $500M–$1B

HQ: Chicago, IL

Health Catalyst

healthcatalyst.com

Big Data & Analytics · Salt Lake City, UT · Est. 2008 · 1001–5000 employees · $500M–$1B

HQ: Salt Lake City, UT

Moderna

modernatx.com

Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com

Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Company Info

astellasgenetherapies.com

600 California St, San Francisco, CA, 94108, United States

Specialization: Pharmaceuticals

Employees: 201-500

Annual Revenue: $50M–$100M

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.